Diagnostics & Research
The Diagnostics & Research industry has a total of 52 stocks, with a combined market cap of $677.56 billion, total revenue of $163.46 billion and a weighted average PE ratio of 45.14.
Market Cap
677.56B
Revenue
163.46B
Profits
15.01B
PE Ratio
45.14
Profit Margin
9.18%
Dividend Yield
0.21%
52 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 183.06B | 1.55% | 2,054,721 | 43.21B |
| 2 | DHR | Danaher Corporation | 149.76B | 1.66% | 3,241,547 | 24.01B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 53.12B | 1.79% | 566,081 | 4.04B |
| 4 | A | Agilent Technologies, Inc. | 34.17B | 2.53% | 983,586 | 6.63B |
| 5 | IQV | IQVIA Holdings Inc. | 32.34B | 2.32% | 1,564,820 | 15.70B |
| 6 | MTD | Mettler-Toledo International Inc. | 27.27B | 2.41% | 111,804 | 3.87B |
| 7 | LH | Labcorp Holdings Inc. | 22.65B | 1.20% | 532,060 | 13.48B |
| 8 | NTRA | Natera, Inc. | 21.64B | -1.32% | 1,202,712 | 1.96B |
| 9 | DGX | Quest Diagnostics Incorporated | 20.02B | 0.20% | 928,416 | 10.52B |
| 10 | WAT | Waters Corporation | 17.67B | 3.96% | 623,116 | 3.05B |
| 11 | ILMN | Illumina, Inc. | 15.54B | 3.83% | 1,671,121 | 4.28B |
| 12 | ICLR | ICON Public Limited Company | 13.71B | 4.26% | 1,444,155 | 8.09B |
| 13 | MEDP | Medpace Holdings, Inc. | 13.15B | 1.90% | 517,599 | 2.23B |
| 14 | QGEN | Qiagen N.V. | 10.67B | 0.53% | 929,116 | 2.04B |
| 15 | RVTY | Revvity, Inc. | 10.55B | 3.33% | 1,610,295 | 2.80B |
| 16 | EXAS | Exact Sciences Corporation | 8.50B | 7.59% | 5,285,133 | 2.94B |
| 17 | CRL | Charles River Laboratories International, Inc. | 7.63B | 1.47% | 2,208,936 | 4.03B |
| 18 | GH | Guardant Health, Inc. | 7.30B | 6.30% | 3,050,188 | 828.85M |
| 19 | RDNT | RadNet, Inc. | 5.26B | 7.56% | 1,945,756 | 1.91B |
| 20 | SHC | Sotera Health Company | 4.47B | 5.79% | 2,338,900 | 1.12B |
| 21 | WGS | GeneDx Holdings Corp. | 3.54B | 5.76% | 918,983 | 362.32M |
| 22 | HTFL | HeartFlow, Inc. | 3.34B | 11.17% | 1,125,957 | 136.17M |
| 23 | VCYT | Veracyte, Inc. | 2.41B | 6.64% | 2,729,080 | 479.13M |
| 24 | TWST | Twist Bioscience Corporation | 1.73B | 4.37% | 3,859,510 | 362.27M |
| 25 | GRAL | GRAIL, Inc. | 1.22B | 1.13% | 1,492,112 | 134.29M |
| 26 | NEOG | Neogen Corporation | 1.20B | 5.93% | 4,423,291 | 894.66M |
| 27 | OPK | OPKO Health, Inc. | 1.07B | 2.27% | 1,979,516 | 664.03M |
| 28 | NEO | NeoGenomics, Inc. | 806.07M | 2.63% | 1,831,633 | 689.19M |
| 29 | FLGT | Fulgent Genetics, Inc. | 666.66M | 3.66% | 248,057 | 303.22M |
| 30 | CDNA | CareDx, Inc | 645.64M | -2.65% | 1,789,589 | 340.83M |
| 31 | CSTL | Castle Biosciences, Inc. | 563.05M | 0.36% | 2,389,463 | 346.27M |
| 32 | MYGN | Myriad Genetics, Inc. | 546.17M | -2.65% | 1,946,767 | 832.90M |
| 33 | PSNL | Personalis, Inc. | 428.31M | 5.69% | 1,282,765 | 80.32M |
| 34 | XGN | Exagen Inc. | 213.66M | 1.57% | 147,213 | 58.86M |
| 35 | MDXH | MDxHealth SA | 136.12M | -4.18% | 116,241 | 94.51M |
| 36 | PRE | Prenetics Global Limited | 99.71M | -0.65% | 28,322 | 41.52M |
| 37 | FONR | FONAR Corporation | 95.95M | 0.86% | 19,125 | 103.02M |
| 38 | BNR | Burning Rock Biotech Limited | 75.37M | 0.72% | 4,073 | 72.11M |
| 39 | IMDX | Insight Molecular Diagnostics Inc. | 70.07M | -2.39% | 15,856 | 4.26M |
| 40 | NOTV | Inotiv, Inc. | 68.02M | -0.75% | 553,935 | 505.30M |
| 41 | BDSX | Biodesix, Inc. | 56.23M | -6.69% | 962,111 | 76.56M |
| 42 | PRPO | Precipio, Inc. | 21.59M | 0.42% | 10,566 | 20.03M |
| 43 | PRPH | ProPhase Labs, Inc. | 13.60M | -7.51% | 12,819,707 | 4.62M |
| 44 | ADVB | Advanced Biomed Inc. | 8.69M | -0.70% | 259,081 | - |
| 45 | STRR | Star Equity Holdings, Inc. | 7.88M | 22.18% | 210,161 | 57.17M |
| 46 | BIAF | bioAffinity Technologies, Inc. | 7.85M | 2.23% | 541,676 | 8.81M |
| 47 | XWEL | XWELL, Inc. | 7.08M | -1.28% | 14,053 | 32.19M |
| 48 | MYNZ | Mainz Biomed N.V. | 5.92M | 17.01% | 597,626 | 893.99K |
| 49 | ISPC | iSpecimen Inc. | 4.62M | 0.87% | 65,418 | 8.06M |
| 50 | CHEK | Check-Cap Ltd. | 3.97M | 1.93% | 40,455 | - |
| 51 | NDRA | ENDRA Life Sciences Inc. | 3.23M | 4.78% | 64,548 | - |
| 52 | APDN | Applied DNA Sciences, Inc. | 2.19M | 3.69% | 93,925 | 3.79M |